Bosch Healthcare Solutions GmbH
Vivalytic Bacterial Meningitis by Bosch: PCR rapid test for medical emergencies
more
Stories about Gesundheit
BIAL Announces First Patient Out in its Phase 2 Clinical Trial of BIA 28-6156 - a Novel Therapy for GBA1 Parkinson's Disease
Porto, Portugal (ots/PRNewswire) - BIAL, a hundred-year-old innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, announced that the first patient has completed the full dose regimen in the ACTIVATE Phase 2 study. BIA 28-6156 is a first-in-class, small molecule for once-daily oral ...
moreNorgine submits Marketing Authorisation Application to the European Medicines Agency for eflornithine (difluoromethylornithine [DFMO]) in high-risk neuroblastoma
London (ots/PRNewswire) - Back to media releases Next media release Norgine today announced that it completed its marketing authorisation application filing to European Medicines Agency (EMA) for eflornithine in high-risk neuroblastoma (HRNB). This follows the submissions in April 2024, via Project Orbis, in ...
moreGerresheimer: FDA grants Tentative Approval of SQ Innovation’s Lasix® ONYU*
moreAccord Healthcare is granted marketing authorisation for IMULDOSA®, ustekinumab biosimilar to Stelara®
London (ots/PRNewswire) - - Accord announces that the European Commission (EC has granted marketing authorisation for Imuldosa® (development code: DMB-3115), a biosimilar to Stelara®, indicated for a range of immune medicated inflammatory diseases. - The EC approval follows a positive opinion issued on 19 October ...
more
25The Future of Nutrition: Dr. Clemens Röhrl on Regional Plant Research and Its Importance for Health and the Environment
more
Strides Pharma International AG
Strides Pharma Consolidates European Business-to-Business Operations in Switzerland
moreEuropean Alliance Against Depression
First European Patient Congress Depression for those affected by depression and their close relations takes place online on December 7, 2024 / Free online-event offers information and experience-sharing
Frankfurt am Main (ots) - The European Patient Congress Depression, hosted by the European Alliance Against Depression (EAAD), will take place on December 7, 2024. This free online-event is designed to support individuals affected by depression and their relatives, providing a platform for expert guidance, patient ...
morePulsenmore Expands Partnership with Clalit Health Services to Deliver 25,000 Home Ultrasound Devices for Remote Prenatal Care
Ramat Gan, Israel (ots/PRNewswire) - Pulsenmore (TASE: PULS), a pioneering provider of home-based ultrasound technology, has announced the renewal and expansion of its strategic partnership with Clalit Health Services, Israel's largest HMO. Over the next five years, Pulsenmore will supply 25,000 units of its ...
moreEpitomee Medical to Present the Epitomee Breakthrough Oral Delivery Platform at PODD 2024 Conference
Caesarea, Israel (ots/PRNewswire) - Epitomee Medical Ltd. (TASE: EPIT) announces today that the company leadership intends to present Epitomee's Oral Delivery of Biologics Platform at the 14th Annual PODD Conference - Partnership Opportunities in Drug Delivery, taking place in Boston, MA, October 28-29, 2024. ...
moreBetter Health Requires More Participation by Young People
Berlin/Gütersloh (ots) - At this year’s World Health Summit in Berlin, the WHO Youth Council presented its vision for healthier societies. The World Health Organization’s Youth Council is calling on policymakers to better leverage the potential of young people. The Bertelsmann Stiftung and major youth organizations support the initiative. Better involvement of and support for young people is essential to creating a ...
moreNorgine Announces Appointment of New CEO Janneke van der Kamp
London (ots/PRNewswire) - Norgine (the "Company"), a leading European specialty pharmaceutical company, has today announced the appointment of Janneke van der Kamp as its new Chief Executive Officer (CEO), effective from 1 January 2025. Current CEO, Chris Bath, has stepped down from his role effective immediately. This change in leadership will support and enhance the Company's mission of bringing transformative medicines ...
more
German Federal Chancellor Scholz, WHO Director-General Dr Tedros and Bill Gates at the World Health Summit 2024 / The world's leading global health conference begins on October 13
Berlin (ots) - The financing of WHO, Germany's role in global health, antimicrobial resistance, Mpox, digitalization - topics like these are on the agenda of this year's World Health Summit from October 13-15 in Berlin. Leading international experts and decision-makers from all sectors will discuss strategies for a ...
moreMSD in Strategic collaboration with Briya for Innovative RWE data analysis projects
Tel Aviv, Israel (ots/PRNewswire) - MSD, a leading multinational pharmaceutical company successfully completes a first-of-its-kind strategic collaboration with Briya, a medical data retrieval network. This groundbreaking partnership enabled innovative data analysis projects on three critical disease areas MSD plays a part in. Leveraging Briya's advanced data platform, ...
moreWort & Bild Verlagsgruppe - Unternehmensmeldungen
You.com and Wort & Bild Verlag Join Forces to Increase Health Information Access with AI
moreEpitomee Medical Announces FDA Clearance of its Capsule, Weight Management Device
Caesarea, Israel (ots/PRNewswire) - Epitomee's Ingestible Capsule, Offers a Safe and Effective Prescription Solution for Adults with BMI of 25-40 looking for Alternative Drug Free Solutions for Their Weight Management Needs alongside diet and exercise. Epitomee Medical Ltd. (TASE: EPIT), announced that the United States Food and Drug Administration (FDA) has officially ...
moreScantox Group acquires Gentronix, a world leader in genetic toxicology
Ejby, Denmark (ots/PRNewswire) - Today Scantox, together with its majority owner Impilo, finalized the acquisition of Gentronix Ltd, a UK based GLP compliant genetic toxicology Contract Research Organization ("CRO"). Gentronix, now integrated into Scantox Group, is well recognized for its high-quality genetic toxicology services and strong scientific engagement, with ...
moreINSIGHTEC; Charles River Laboratories International, Inc.
Charles River and Insightec Announce Strategic Collaboration to Advance Therapeutic Development Utilizing Focused Ultrasound in Neuroscience
Wilmington, Mass., Miami and Haifa, Israel (ots/PRNewswire) - Collaboration stands to advance novel therapeutic applications across multiple neurologic conditions Charles River Laboratories International, Inc. (NYSE: CRL) and Insightec, a global healthcare company dedicated to using focused ultrasound to transform ...
more
Bosch Healthcare Solutions GmbH
PCR rapid test for 3 important gastroenteritis pathogens for Vivalytic by Bosch now available / World’s first fully automated PCR test for detection of C. difficile, norovirus, and rotavirus at the sampling point
moreFitLine becomes Official Partner of the ATP Tour
moreVirchow Foundation for Global Health
2Lucy Gilson and Johan Rockström awarded the Virchow Prize 2024
moreMedasense Announces a Strategic Agreement With Global Medical Company, Nihon Kohden Corporation
Ramat Gan, Israel (ots/PRNewswire) - Medasense, a global leader in pain monitoring solutions, is proud to announce a strategic partnership with Nihon Kohden for the exclusive distribution of its revolutionary pain monitoring device in Japan. This partnership is intended to transform pain management practices across Japanese healthcare facilities, offering a significant ...
moreLabguru (BioData) Announces New Distribution Partnership of its Electronic Lab Notebook Module to Help Streamline Life Sciences Research
Boston (ots/PRNewswire) - New distribution agreement with Thermo Fisher Scientific allows Thermo Fisher to offer Labguru's cutting-edge Electronic Lab Notebook module together with Thermo Fisher's renowned suite of Laboratory Information Management System (LIMS) and lab operations software solutions, amplifying ...
moreBosch Healthcare Solutions GmbH
PCR rapid test for Candida auris for Vivalytic by Bosch now available / World’s first fully automated PCR test for detection of the multidrug-resistant fungus at the point of care
Waiblingen (ots) - - Vivalytic test detects Candida auris in under an hour at the point of care, making it the world’s first test suitable for screenings. - Candida auris infection rates are on the rise in Germany and can cause severe infections, for example of the bloodstream (sepsis). - Hospitals can use the new ...
more
- 2
Gerresheimer partners with RxCap to offer connected adherence solutions
more NESPRESSO WILL INVEST 20 MILLION USD IN DRC TO SUPPORT THE COFFEE GROWING COMMUNITY AND THE REVIVAL OF THE SPECIALTY COFFEE
Vevey, Switzerland (ots/PRNewswire) - Focusing on an increased sourcing of high-quality coffee, as well as implementing regenerative practices, gender equality programs and projects to increase access to healthcare and clean water. Nespresso aims to continue to support the local community and economy by investing 20 ...
moreFennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
Research Triangle Park, N.C. and Uxbridge, England (ots/PRNewswire) - Agreement pairs Norgine's commercial expertise and leading European footprint with PEDMARQSI™, the first and only approved therapy in the European Union and U.K. for reducing the risk of cisplatin-induced hearing loss in pediatric patients with ...
moreResearch Success in Rare Disease / RHEACELL receives positive signal for accelerated stem cell development program in rare ‚Butterfly Disease‘
moreHearing loss company Acousia announces first patient enrolled in its Phase 2 PROHEAR-Study
Tübingen, Germany (ots) - Acousia Therapeutics GmbH, a Tübingen-based clinical stage biotech company focused on the enhancement and preservation of natural hearing, just announced the randomization of the first patient for the PROHEAR-Study. The PROHEAR-Study is a placebo-controlled, Phase 2a study with split-body design, which investigates the otoprotective efficacy ...
moreRelaunch Gipsbomber - SOS-emergency-call-centre launches winter season
Innsbruck (ots) - Flights from Innsbruck to BENELUX are already planned and will bring injured holidaymakers home. After its launch last winter, the "Gipsbomber" is experiencing a real relaunch thanks to the SOS-Emergency-Call-Centre. "For over 17 years, there was no alternative to the DASH7 for transporting injured holidaymakers home, but now it's the Dornier 328-100 ...
more
Previous12345678Next